Literature DB >> 27767979

Soluble CD40 ligand profiles in patients with septic shock.

Patrícia Napoleão1, Ekaterina Potapova1, Sara Moleirinho1, Carlota Saldanha1,2, António Messias3.   

Abstract

AIM: Soluble CD40 ligand (sCD40L) has been considered as a marker of thrombosis and inflammation in several diseases, including sepsis. Recent studies challenge this view and point to a role of sCD40L in vascular and endothelial function. An indication of that association in sepsis has not been obtained so far. Therefore, herein we evaluated association between sCD40L and markers of hemorheology and inflammation on context of septic shock.
METHODS: Time-changes of sCD40L levels over 72 hours of Intensive Care Unit (ICU) internment were assessed in 22 patients with septic shock and compared with 36 healthy volunteers. Association of sCD40L levels with erythrocyte deformability and aggregation (as markers of hemorheology), plasma concentrations of haemoglobin (Hb, as markers of endothelial function) and white blood cells (WBC) count (as marker of low-grade inflammation) were assessed in patients with septic shock.
RESULTS: At ICU admission, sCD40L concentrations in patients with septic shock were lower (p = 0.024) than levels of healthy volunteers. However, sCD40L did not change over 72 hours of internment (F = 2.1, p = 0.137). Soluble CD40L levels in patients with septic shock at ICU admission correlate with concentrations of Hb (r = 0.61, p = 0.00) and WBC count (r = 0.63, p = 0.00), but not to erythrocyte deformability (r≥0.157, p≤0.235) and aggregation (r≥-0.109, p≤0.192).
CONCLUSIONS: These results seem to highlight a possible association of sCD40L to endothelial function and inflammation in septic shock context.

Entities:  

Keywords:  Sepsis; haemoglobin; hemorheology; inflammation; sCD40L

Mesh:

Substances:

Year:  2016        PMID: 27767979     DOI: 10.3233/CH-168026

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  3 in total

1.  Changes in inflammatory factors and prognosis of patients complicated with non-alcoholic fatty liver disease undergoing coronary artery bypass grafting.

Authors:  Lei Wang; Yuanming Li; Xiaojin Gong
Journal:  Exp Ther Med       Date:  2017-11-09       Impact factor: 2.447

2.  PMMA-Based Continuous Hemofiltration Modulated Complement Activation and Renal Dysfunction in LPS-Induced Acute Kidney Injury.

Authors:  Alessandra Stasi; Rossana Franzin; Chiara Divella; Fabio Sallustio; Claudia Curci; Angela Picerno; Paola Pontrelli; Francesco Staffieri; Luca Lacitignola; Antonio Crovace; Vincenzo Cantaluppi; Davide Medica; Claudio Ronco; Massimo de Cal; Anna Lorenzin; Monica Zanella; Giovanni B Pertosa; Giovanni Stallone; Loreto Gesualdo; Giuseppe Castellano
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

Review 3.  Platelets as Key Factors in Inflammation: Focus on CD40L/CD40.

Authors:  Fabrice Cognasse; Anne Claire Duchez; Estelle Audoux; Theo Ebermeyer; Charles Antoine Arthaud; Amelie Prier; Marie Ange Eyraud; Patrick Mismetti; Olivier Garraud; Laurent Bertoletti; Hind Hamzeh-Cognasse
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.